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a  b  s  t  r  a  c  t
BACKGROUND:  The  mean  survival  is less  than  6 months  in  hepatocellular  carcinoma  (HCC)  patients  with
extrahepatic  metastasis.  Gastrointestinal(GI)  bleeding  frequency  due  to HCC  invasion  is 0.05%  to  2.0%,
and may  be fatal.
CASE PRESENTATION:  We  encountered  a case  of  HCC  with  direct  invasion  to the  gastrium  that  caused
a  life-threatening  upper  GI  bleeding.  Our  patient  was  a  62 year  old  male  who  was  a  heavy  smoker  and
drinker  for  almost  30 years.  He had  several  upper  GI bleeding  episodes  during  the  previous  6 months.
Computed  tomography  (CT)  revealed  a 13 cm  liver  tumour  directly  invading  the  gastrium.  Partial  hepatic
resection  and  subtotal  gastrectomy  were  performed.  Unfortunately,  the  patient  died  at the  intensive  care
unit  postoperatively  due  to  hepatic  failure.
DISCUSSION:  Although  the  prognosis  of  HCC  that has  invaded  the gastrium  is very  poor due  to  the advanced
stage  of the  disease,  surgical  resection  may  be a favourable  treatment  option  for  patients  with  a  massive
upper GI  bleeding.
CONCLUSIONS:  The  incidence  of  patients  with  massive  bleeding  due  to gastric  invasion  of  HCC  is  low,  and
only a few  cases  have  been  reported  in the literature.  Our  purpose  while  presenting  this rare  case  is  to
increase  the  awareness  about  the  issue.
©  2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Hepatocellular carcinoma (HCC), which constitutes more than
0% of primary liver cancers, is a major global health problem [1].
lobally, HCC is the ﬁfth most common type of cancer and the
hird leading cause of cancer-related death [2]. Its incidence has
n increasing trend in the United States and European countries,
ut there are some geographical differences as well [3]. Approx-
mately 90% of HCCs are associated with underlying risk factors
hich are most commonly found as chronic viral hepatitis (types B
nd C), alcohol intake and aﬂatoxin exposure. Smoking is known to
e a co-factor as heavy smokers have higher risks [4]. In the general
opulation, the incidence of HCC is increased among patients with
IV infection indicating that HIV is also an additive co-factor which
xacerbates the risk of HCC in patients with chronic viral hepatitis
5]. Extrahepatic metastasis is found in more than 15% of patients at
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the time of diagnosis and HCC is commonly metastasised to lungs,
lymph nodes, bone and adrenal glands [6]. The mean survival is
less than 6 months for patients with extrahepatic metastasis [7].
In patients with HCC, 30% of cancer-related deaths are due to hep-
atic failure, and 10% are due to gastrointestinal (GI) bleeding. GI
metastasis is reported as 0.4%–2.0% [8]. GI bleeding frequency due
to HCC direct invasion is 0.05%–2.0%, and may  be fatal [9]. In one
study, all patients died within 9 months [9]. The median survival
was reported as 4 weeks in patients with HCC and GI involvement
in another study [10]. The incidence of patients with massive bleed-
ing due to gastric invasion is low, and only a few cases have been
reported in the literature. We  presented this rare case to increase
awareness about the issue.
2. Case
A 62 year old male patient had been smoking 2 packs of
cigarettes/day for more than 30 years, and the alcohol con-
sumption of the patient was  >80 g/day. The cause of death of
the patient’s father was lung cancer. The patient had dyspeptic
complaints, and he received medical treatment. The patient had
received medical treatment for dyspeptic complaints in another
health centre initially. The tumour with 15 × 13 cm diameter was
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. Macroscopic image of tumor.
Fig. 3. Atypic mitosis in tumor tissue.Fig. 1. Endoscopic image of tumor.
rst diagnosed in the gastric antrum 6 months previously during
breoptic endoscopy performed due to upper GI bleeding (Fig. 1).
ndoscopic haemostasis was successful to stop bleeding and a
iopsy was performed. Gastric metastasis of HCC was reported
n the pathological examination. The patient had two upper GI
leeding episodes within a one month interval and the bleeding
as controlled by supportive treatment. In oral and IV contrasted
T examination, a mass lesion was observed. This lesion which had
3 × 11 cm diameter with gastric lumen involvement, containing
ir images in the centrum and compact content; it extended
etween the hepatic hilus and distal part of the stomach and
ould not be differentiated from adjacent fatty planes. Multiple
ymphadenopathies were detected in the hepatic hilus, para-aortic
nd hepatogastric regions. Activity distributions were evaluated
s normal in whole body bone scintigraphy. In echocardiography,
eft ventricular hypertrophy, mild mitral and tricuspid insufﬁ-
iency, dilations of aortic root and left atrium were reported.
he laboratory test results were normal for tumour markers
Carcinoembryonic antigen (CEA) = 3.06 ng/ml, carbohydrate anti-
en (CA 19-9) = 11.19 U/ml, alpha-fetoprotein (AFP) = 2.82 IU/ml),
nd albumin = 2.2 g/L, total bilirubin = 0.77 mg/dl, AST = 30 IU/L,
LT = 38 IU/L, leukocyte = 10,400/mm3, haemoglobin = 9 g/dl,
aematocrit = 28%, platelets = 390,000/mm3. The coagulation pro-
le indicated INR of 1.12 and an activated partial thromboplastin
ime of 26. Serum HIV, hepatitis B and C antigens were all negative.
he patient was evaluated as having advanced stage cancer,
nd cisplatin, docetaxel and capecitabine treatment protocol
as given by the oncology clinic. Oral nutrition of the patient
as planned according to the oncological treatment regimen.
owever, the patient refused to follow the course of oncological
reatment, so chemotherapy was administered only once. The
eneral status of the patient deteriorated and he had a massive
nd life-threatening upper GI bleeding while he was  having
he supportive treatment at the internal medicine clinic. The
aemoglobin value was reduced from 9 g/dl to 3 g/dl, and the
atient was transfused with 6 units of erythrocyte suspension
nd resuscitative treatments were administered. However, the
aemodynamics of the patient did not improve, so emergency
urgery was performed. During the exploration, a perforated and
leeding mass with necrosis and approximately 18 cm in diameter
as observed, which originated from the left lobe of the liver
nvading the gastrium (Fig. 2). Subtotal gastrectomy and partial
epatic resection were performed. Pathological examination of
peration material revealed HCC with negative surgical borders
Figs. 3–5 ). Immunohistochemical ﬁndings were Heppar-1 (+),
inusoidal staining (+), CD10 canalicular staining (+), MUCSAC
ocal (+), P53 (−), AFP (−), CK19 (−), CK20 (−), and CDX2 (−). Fig. 4. Heppar-1 immunohistochemical staining.
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The Study Of The Liver, European Organisation for Research and Treatment ofig. 5. Tumor islands located in the lamina propria of the stomach tissue ×40.
orphological signs were evaluated with immunohistochemical
igns. Although the tumour was observed diffusely in the gastrium,
ts lamina propria extensions were observed in two  focus with very
mall sizes. We  also observed that there was  no paraneoplastic
esion accompanying the tumour in the gastric mucosa, which was
lcerated due to tumour in many areas, and that hepatic tissue
howed a nodular structure formed by anastomosed ﬁbrotic bands.
hus, it was decided that the primary focus was  the liver, and the
umour was diagnosed as HCC. However, the patient died at the
ntensive care unit postoperatively due to hepatic failure.
. Discussion
Generally, oesophageal varices or peptic ulcer disease cause GI
leeding in HCC cases. When there is hematemesis, it is considered
hat hypervascular HCC directly invades the gastrium. Although it is
ifﬁcult to implant a clip rapidly via endoscopy, it may  be a solution.
owever, surgery should usually be performed in these patients. GI
nvolvement is rare in HCC, but if present, it directly involves most
ommonly the gastrium, duodenum, and colon [11–13]. In our case,
here was direct gastric invasion, and the massive bleeding was a
erious danger to life. Some predisposing factors have been pro-
osed for rarely encountered direct invasion. These propositions
ere that the GI wall was affected by inﬂammatory response as the
esult of regional therapies such as transcatheter arterial emboli-
ation (TAE), and so it adhered to the liver or tumour capsule [11].
herefore, vital tumour tissue can easily invade the GI system. How-
ver, GI involvement has also been reported in HCC patients who
id not receive any treatments [12]. Thus, it is assumed that the
ain factors in direct invasion are growth pattern, size, and loca-
ion of these masses, rather than previous treatment modalities.
he majority of patients with direct invasion have large (>5 cm in
ize) subcapsular HCC with exophytic growth pattern [12]. Simi-
arly, the tumour in our case was located subcapsularly and very
arge.
If the patient has sufﬁcient liver reserve, surgical removal of the
leeding tumour should be considered ﬁrst [10,14]. It was reported
n other case series that surgical intervention prolonged survival
ith the median survival rate of 9.7 months when compared to
.0 months with nonsurgical therapy [13,15]. However, prognosis
s quite bad in HCC patients with GI involvement due to massive
leeding and hepatic failure. Non-surgical methods in sustaining
aemostasis are TAE, injection of ethanol or adrenalin or both, and
adiotherapy [16,17].PEN  ACCESS
ery Case Reports 26 (2016) 69–72 71
HCC which is metastasised to the gastrium should be differen-
tiated especially from hepatoid adenocarcinoma of the gastrium
which is metastasised to the liver. Serious lymphovascular inva-
sions such as venous tumour emboli which may result in early
metastasis, especially in liver and other organs, may  be observed in
these cancer types [18]. Moreover, hepatoid adenocarcinoma of the
gastrium is very similar to HCC due to its mutual clinical and patho-
logical structures such as high AFP level, hepatoid morphology and
AFP, polyclonal CEA and antitrypsin presence [19].
Although GI bleeding due to HCC involvement is rare, the possi-
bility of direct gastric invasion should be considered in HCC patients
who have hematemesis and/or melena in addition to the com-
mon bleeding causes such as varices and peptic ulcer. Besides, the
repetition of TAE, intra-arterial chemotherapy, radiotherapy, and
individualised treatmentplans have recently increased survival in
unresectable HCC patients [20], and thus it is expected that GI
involvement will be more commonly encountered in HCC patients
in the near future.
In conclusion, while the prognosis of gastric invasion of HCC is
usually poor because of the advanced stage of the disease, surgery
can be suitable treatment choice in patients before the potential
complications occurred.
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